Predictions
Quoin Pharmaceuticals Ltd. ADR
Start price
Target price
Perf. (%)
€0.65
22.02.23
22.02.23
-
22.02.24
22.02.24
-23.57%
23.02.24
23.02.24
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
Newron Pharmaceut.
Start price
Target price
Perf. (%)
€7.58
21.02.23
21.02.23
-
21.02.24
21.02.24
-37.99%
24.04.23
24.04.23
Probably not worthwhile Investment
Orpea Nom.
Start price
Target price
Perf. (%)
€2.58
20.02.23
20.02.23
-
20.02.24
20.02.24
-1.16%
05.03.23
05.03.23
Could be very worthwhile Investment >20% year
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.46
16.02.23
16.02.23
-
16.02.24
16.02.24
18.24%
02.04.23
02.04.23
Could be worthwhile Investment >10% per year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€4.52
15.02.23
15.02.23
-
15.02.24
15.02.24
53.76%
02.04.23
02.04.23
Could be worthwhile Investment >10% per year
Inovio Pharma
Start price
Target price
Perf. (%)
€1.47
13.02.23
13.02.23
€0.30
13.02.24
13.02.24
-63.81%
14.02.24
14.02.24
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Lannett Co. Inc.
Start price
Target price
Perf. (%)
€0.015
13.02.23
13.02.23
€5.20
-
21.02.23
21.02.23
Could be very worthwhile Investment >20% year
Orpea Nom.
Start price
Target price
Perf. (%)
€2.17
08.02.23
08.02.23
-
08.02.24
08.02.24
-9.35%
03.04.23
03.04.23
Could be very worthwhile Investment >20% year
MyMD Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.04
07.02.23
07.02.23
€1.00
07.02.24
07.02.24
-7.35%
18.02.23
18.02.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Cidara Therapeutics Inc
Start price
Target price
Perf. (%)
€1.58
07.02.23
07.02.23
€1.00
07.02.24
07.02.24
-5.06%
18.02.23
18.02.23
Probably not worthwhile Investment
Below average Management
Bad culture
Orpea Nom.
Start price
Target price
Perf. (%)
€2.36
07.02.23
07.02.23
€4.00
07.02.24
07.02.24
9.32%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Eiger Biopharmaceuticals Inc
Start price
Target price
Perf. (%)
€2.10
07.02.23
07.02.23
-
07.03.23
07.03.23
18.88%
10.02.23
10.02.23
Reata Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€47.20
07.02.23
07.02.23
€50.00
07.02.25
07.02.25
100.21%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Actinium Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
06.02.23
06.02.23
€20.00
31.12.25
31.12.25
-29.20%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€2.30
06.02.23
06.02.23
€3.50
31.12.25
31.12.25
-16.01%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€2.59
06.02.23
06.02.23
€4.00
31.12.25
31.12.25
-40.15%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year